OncoCyte Corporation OCX
€ 2.61
-0.06%
Quartalsbericht 2024-Q3
hinzugefügt 12.11.2024
OncoCyte Corporation Bilanz 2011-2024 | OCX
Bilanz Jährlich OncoCyte Corporation
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
- | - | -3.24 M | -19 M | -6.89 M | -5.73 M | -9.66 M | -8 M | 5.63 M | 2.86 M | - | - |
Langfristige Schulden |
- | - | 1.51 M | 1.9 M | 347 K | 1.07 M | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
- | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | 12.9 M | 4.58 M | 534 K | 1.36 M | 310 K | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
12.1 M | 14.1 M | 9 M | 4.44 M | 5.56 M | 4.45 M | 4.28 M | - | - | - | - | - |
Gesamtverbindlichkeiten |
60.5 M | 94.3 M | 21.9 M | 9.02 M | 6.1 M | 5.81 M | 4.58 M | 2.31 M | 7.43 M | 4.67 M | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-261 M | -188 M | -124 M | -93.7 M | -71.3 M | -54.7 M | -35.3 M | -24.1 M | -15.4 M | -10.4 M | - | - |
Vermögenswerte |
100 M | 160 M | 55.4 M | 39.9 M | 9.52 M | 10.2 M | 14.4 M | 12.7 M | 6.36 M | 8.29 M | - | - |
Zahlungsmittel |
20 M | 32.9 M | 7.14 M | 22.1 M | 8.03 M | 7.6 M | 10.2 M | 8 M | 257 K | - | - | - |
Buchwert |
39.6 M | 65.2 M | 33.5 M | 30.8 M | 3.42 M | 4.4 M | 9.86 M | 10.4 M | -1.07 M | 3.62 M | - | - |
Gesamtes Eigenkapital |
34.3 M | 65.2 M | 33.5 M | 30.8 M | 3.42 M | 4.4 M | 9.86 M | 10.4 M | -1.07 M | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich OncoCyte Corporation
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | 196 K | 221 K | 221 K | 19 K | 39 K | 58 K | 77 K | 100 K | 134 K | 187 K | - | - | 187 K | 1.87 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
60.5 M | 52 M | 54.1 M | 49.3 M | 39.1 M | 39.2 M | - | 60.5 M | 75.4 M | 83 M | 89.3 M | 94.3 M | 69 M | 74.7 M | 22.7 M | 21.9 M | 21.9 M | 21.9 M | 21.9 M | 9.02 M | 9.02 M | 9.02 M | 9.02 M | 6.1 M | 6.1 M | 6.1 M | 6.1 M | 5.81 M | 5.81 M | 5.81 M | 5.81 M | 4.58 M | 4.58 M | 4.58 M | 4.58 M | 2.31 M | 2.31 M | 2.31 M | 2.31 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-317 M | -304 M | -299 M | -290 M | -262 M | -262 M | -262 M | -261 M | -216 M | -206 M | -198 M | -188 M | -152 M | -138 M | -128 M | -124 M | -124 M | -124 M | -124 M | -93.7 M | -93.7 M | -93.7 M | -93.7 M | -71.3 M | -71.3 M | -71.3 M | -71.3 M | -54.7 M | -54.7 M | -54.7 M | -54.7 M | -35.3 M | -35.3 M | -35.3 M | -35.3 M | -24.1 M | -24.1 M | -24.1 M | -24.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
70.2 M | 74.7 M | 71 M | 74.9 M | 81.6 M | 87.5 M | - | 100 M | 157 M | 171 M | 146 M | 160 M | 168 M | 177 M | 129 M | 55.4 M | 55.4 M | 55.4 M | 55.4 M | 39.9 M | 39.9 M | 39.9 M | 39.9 M | 9.52 M | 9.52 M | 9.52 M | 9.52 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 14.4 M | 14.4 M | 14.4 M | 14.4 M | 12.7 M | 12.7 M | 12.7 M | 12.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
3.36 M | 9.26 M | 5.58 M | 9.43 M | 13.8 M | 17.4 M | - | 20 M | 32.1 M | 44.8 M | 20.4 M | 35.6 M | 43.3 M | 46.5 M | 58.9 M | 7.14 M | 7.14 M | 7.14 M | 7.14 M | 22.1 M | 22.1 M | 22.1 M | 22.1 M | 8.03 M | 8.03 M | 8.03 M | 8.03 M | 7.6 M | 7.6 M | 7.6 M | 7.6 M | 10.2 M | 10.2 M | 10.2 M | 10.2 M | 8 M | 8 M | 8 M | 8 M | 257 K | - | - | - | 101 K | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
9.71 M | 22.7 M | 16.9 M | 25.6 M | 42.5 M | 48.3 M | - | 39.6 M | 81.9 M | 88.1 M | 57 M | 65.2 M | 99.3 M | 103 M | 107 M | 33.5 M | 33.5 M | 33.5 M | 33.5 M | 30.8 M | 30.8 M | 30.8 M | 30.8 M | 3.42 M | 3.42 M | 3.42 M | 3.42 M | 4.4 M | 4.4 M | 4.4 M | 4.4 M | 9.86 M | 9.86 M | 9.86 M | 9.86 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
9.71 M | 22.7 M | 11.6 M | 20.5 M | 36.1 M | 42.2 M | 36.5 M | 34.3 M | 76.9 M | 83.2 M | 57 M | 65.2 M | 99.3 M | 103 M | 107 M | 33.5 M | 33.5 M | 33.5 M | 33.5 M | 30.8 M | 30.8 M | 30.8 M | 30.8 M | 3.42 M | 3.42 M | 3.42 M | 3.42 M | 4.4 M | 4.4 M | 4.4 M | 4.4 M | 9.86 M | 9.86 M | 9.86 M | 9.86 M | 10.4 M | 10.4 M | 10.4 M | 10.1 M | -1.07 M | - | - | - | 3.62 M | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung